1. Home
  2. GLOB vs ITGR Comparison

GLOB vs ITGR Comparison

Compare GLOB & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globant S.A.

GLOB

Globant S.A.

HOLD

Current Price

$66.31

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Integer Holdings Corporation

ITGR

Integer Holdings Corporation

HOLD

Current Price

$86.90

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLOB
ITGR
Founded
2003
1970
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.7B
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
GLOB
ITGR
Price
$66.31
$86.90
Analyst Decision
Buy
Buy
Analyst Count
14
7
Target Price
$93.07
$86.67
AVG Volume (30 Days)
1.0M
566.6K
Earning Date
02-19-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.19
2.42
Revenue
$2,484,891,000.00
$1,831,074,000.00
Revenue This Year
$3.37
$9.58
Revenue Next Year
$1.72
N/A
P/E Ratio
$28.65
$35.12
Revenue Growth
5.56
9.54
52 Week Low
$54.36
$62.00
52 Week High
$228.98
$146.36

Technical Indicators

Market Signals
Indicator
GLOB
ITGR
Relative Strength Index (RSI) 49.09 72.36
Support Level $62.00 $84.41
Resistance Level $69.81 $86.05
Average True Range (ATR) 3.31 2.25
MACD -0.40 0.39
Stochastic Oscillator 47.08 91.68

Price Performance

Historical Comparison
GLOB
ITGR

About GLOB Globant S.A.

Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

Share on Social Networks: